Mirum Pharmaceuticals to share phase 3 LIVMARLI study results
Covered in this story
Analyst targets on Mirum Pharmaceuticals Inc
- Citizens JMP: $88 → $144 by Sep 2027 · Market Outperform via Investing.com
- Stifel: $88 → $136 by Sep 2027 · Buy via Investing.com
- H.C. Wainwright: $88 → $140 by Sep 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $MIRM yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Mirum Pharmaceuticals Inc →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.